Biaryl sulfonamides and methods for using same

Details for Australian Patent Application No. 2004200247 (hide)

Owner Wyeth

Inventors Cole, Derek Cecil; Du, Xuemei; Hotchandani, Rajeev; Wu, Jun Jun; Li, Wei; Li, Jianchang; Hu, Yonghan; Lovering, Frank; Levin, Jeremy Ian; Xiang, Jason Shaoyun; Rush III, Thomas Saltmarsh

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004200247

Priority Unknown 22.12.03 US; 60/526,840 04.12.03 US

Filing date 8 January 2004

Wipo publication date 23 June 2005

International Classifications

C07D 307/85 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 231/14 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 261/18 Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 307/82 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 285/06 Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 307/68 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/80 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 235/12 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 263/54 Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 407/10 Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 491/06 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 513/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

C07D 417/10 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C12Q 001/37 Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase

C12N 009/99 Enzymes, e.g. ligases (6.) - Enzyme inactivation by chemical treatment

C07D 277/56 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 405/10 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 235/24 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/10 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 333/70 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 209/42 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61P 035/00 Antineoplastic agents

A61P 025/00 Drugs for disorders of the nervous system

A61P 019/04 Drugs for skeletal disorders

A61P 043/00 Drugs for specific purposes, not provided for in groups

A61P 017/02 Drugs for dermatological disorders

A61P 017/00 Drugs for dermatological disorders

A61K 038/55 Medicinal preparations containing peptides - Protease inhibitors

A61K 031/401 - Proline

A61K 031/4439

A61K 031/42 - Oxazoles

A61K 031/4155 - not condensed and containing further heterocyclic rings

A61K 031/433 - Thiadiazoles

A61K 031/357 - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 031/4162 - condensed with heterocyclic ring systems

A61K 031/425 - Thiazoles

A61K 031/427 - not condensed and containing further heterocyclic rings

A61K 031/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

Event Publications

12 February 2004 Complete Application Filed

  Priority application(s): Unknown 22.12.03 US; 60/526,840 04.12.03 US

23 June 2005 Application Open to Public Inspection

  Published as AU-A-2004200247

3 August 2006 Amendment Made

  The nature of the amendment is: Add the coinventor Tam, Steve Yikkai

6 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004200248-Wellbore Casing

2004200246-Wellbore Casing